What are the imaging indications for urinary tract infections (UTIs) in pediatric (peds) patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Imaging Indications for Pediatric UTI

Imaging recommendations for pediatric UTI are highly age-dependent, with renal and bladder ultrasound being the primary initial study for most children, while routine imaging is generally not indicated for children >6 years with uncomplicated first febrile UTI. 1

Age-Based Imaging Algorithm

Infants <2 Months of Age

Renal and bladder ultrasound (RBUS) is the essential first-line imaging study for all infants <2 months with first febrile UTI 1. This age group has the highest risk for underlying urologic abnormalities and bacteremia (4-36.4% of cases) 2.

For male infants specifically:

  • Voiding cystourethrography (VCUG) should be strongly considered to exclude posterior urethral valves and detect vesicoureteral reflux (VUR), which is more common in males 1
  • VCUG can be safely avoided if the infant has E. coli infection, normal RBUS, and is <3 months old 1
  • If RBUS is abnormal, poor urine flow exists, or family history of VUR is present, VCUG becomes more important 1

For female infants:

  • Nuclear medicine cystography may be considered as an alternative to VCUG (lower radiation exposure) 1

DMSA renal scan considerations:

  • Can be performed acutely to detect pyelonephritis; if normal, VCUG may be avoided in >50% of cases 1
  • However, NICE guidelines do not recommend DMSA for infants <6 months responding well to treatment within 48 hours 1

Children 2 Months to 6 Years

RBUS is the primary imaging study recommended after first febrile UTI 1. The American Academy of Pediatrics specifically recommends RBUS for children 2-24 months with febrile UTI 1.

Important caveat: RBUS has poor sensitivity (5-28%) for detecting VUR and should not be considered a screening test for genitourinary abnormalities 3. RBUS and VCUG provide complementary but different information 3.

VCUG indications in this age group:

  • After second febrile UTI (AAP guidelines) 1
  • After first febrile UTI if RBUS shows abnormalities 1
  • For children <6 months with atypical UTI 1
  • For children 6 months to 3 years with atypical UTI AND abnormal RBUS, poor urine flow, or family history of VUR 1

Timing considerations for RBUS:

  • Delaying RBUS reduces false-positive dilation findings; for each additional day of delay, odds of detecting dilation decrease by approximately 2% 4
  • This suggests waiting until acute inflammation resolves may prevent unnecessary follow-up testing 4

Children >6 Years of Age

No routine imaging is indicated for first febrile UTI with appropriate response to treatment 1. The incidence of new-onset UTI is low in this age group and typically associated with behavioral abnormalities, dysfunctional elimination syndrome, or sexual activity in adolescents 1.

Exceptions requiring RBUS:

  • Poor urine flow 1
  • Abdominal or bladder mass 1
  • Elevated creatinine 1
  • Septicemia 1
  • Failure to respond to appropriate antibiotics within 48 hours 1
  • Non-E. coli organisms 1

Consensus opinion: Despite lack of evidence, RBUS may still be useful based on common clinical practice 1

Atypical or Recurrent UTI (Any Age)

Atypical UTI is defined as: seriously ill appearance, poor urine flow, abdominal/bladder mass, elevated creatinine, septicemia, failure to respond within 48 hours, or non-E. coli infection 2.

Recurrent UTI is defined as: ≥2 episodes of pyelonephritis, OR 1 pyelonephritis plus ≥1 cystitis episode, OR ≥3 cystitis episodes 2.

Recommended imaging:

  • RBUS is usually appropriate to detect underlying abnormalities, calculi, or complications like renal/perirenal abscess 1
  • VCUG or voiding urosonography (VUS) is usually appropriate given increased VUR prevalence (35-74% in recurrent UTI) 1
  • Nuclear medicine cystography may be appropriate (though evidence is older than other modalities) 1

CT abdomen/pelvis with IV contrast:

  • Reserved for suspected complications such as renal abscess or xanthogranulomatous pyelonephritis 1
  • Not for routine evaluation 1

DMSA renal scan:

  • Recommended 4-6 months after atypical/recurrent infection in children <3 years 1
  • For recurrent infection in children >3 years 1
  • Normal DMSA may exclude high-grade reflux and avoid invasive VCUG 1
  • Approximately 15% of children develop renal scarring after first UTI 2

Follow-Up Imaging for Established VUR

Multiple modalities are appropriate:

  • RBUS every 12 months to monitor renal growth and parenchymal scarring (detects ~40% of scarring) 1
  • VUS, VCUG, or nuclear medicine cystography for reflux reassessment 1
  • Longer intervals between studies for lower-grade VUR; shorter for grades III-V, bladder/bowel dysfunction, or older age 1

DMSA considerations:

  • May be appropriate to detect new renal scarring, especially after febrile UTI or when RBUS is abnormal 1

Key Pitfalls to Avoid

  • Do not use RBUS as a screening test for VUR—it has very poor sensitivity and provides different information than VCUG 3
  • Do not perform RBUS too early—acute inflammation causes false-positive dilation findings 4
  • Do not routinely image children >6 years with uncomplicated first UTI—yield is extremely low 1
  • Do not skip VCUG in male infants <2 months—posterior urethral valves must be excluded 1
  • Do not order CT routinely—reserve for suspected complications only 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Complicated Urinary Tract Infections in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.